M Reuel Friedman1, Ron Stall, Anthony J Silvestre, Chongyi Wei, Steve Shoptaw, Amy Herrick, Pamela J Surkan, Linda Teplin, Michael W Plankey. 1. aDepartment of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh bCenter for LGBT Health Research, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania cDepartment of Behavioral and Community Health Sciences, Graduate School of Public Health, University of California-San Francisco, San Francisco dDepartment of Epidemiology and Biostatistics, School of Medicine, University of California-San Francisco, San Francisco eDepartment of Family Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California fDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland gDepartment of Medical Social Sciences, Northwestern University, Chicago, Illinois hDepartment of Medicine, Georgetown University Medical Center, Washington, DC, USA.
Abstract
OBJECTIVES: The objective of this study is to determine associations between intertwining epidemics (syndemics) and HIV medication adherence and viral load levels among HIV-positive MSM and to test whether adherence mediates the relationship between syndemics and viral load. DESIGN: We analysed participant data collected between 2003 and 2009 from the Multicenter AIDS Cohort Study, a prospective HIV/AIDS cohort study in four U.S. cities. METHODS: We conducted longitudinal analyses (repeated measures mixed models) to assess whether differences in viral load levels, undetectable viral load and self-reported HIV medication adherence were associated with count of syndemic conditions (substance use, depression symptoms and sexual risk behaviour, range 0-3), adjusting for race/ethnicity, age and income. Mediation analyses were conducted using structural equation modelling and the SAS %mediate macro. RESULTS: Syndemics count was associated with higher viral loads (P < 0.0001) and lower adherence (P < 0.0001). Increased counts of concomitant syndemics were associated with viral load (P < 0.01), detectable viral load (P < 0.05) and adherence (P < 0.001). Black MSM experienced worse outcomes across domains than white MSM (P < 0.0001) and experienced higher overall rates of syndemics (P < 0.01). Adherence significantly mediated the relationship between syndemics and viral load, accounting for an estimated 32.3% of the effect (P < 0.05). CONCLUSION: Effectively lowering viral load levels among MSM has implications for both HIV/AIDS prevention and care. Our findings suggest that integrating substance use interventions, mental healthcare and sexual risk prevention into standard HIV care may be necessary to optimize treatment and Treatment as Prevention (TasP) models.
OBJECTIVES: The objective of this study is to determine associations between intertwining epidemics (syndemics) and HIV medication adherence and viral load levels among HIV-positive MSM and to test whether adherence mediates the relationship between syndemics and viral load. DESIGN: We analysed participant data collected between 2003 and 2009 from the Multicenter AIDS Cohort Study, a prospective HIV/AIDS cohort study in four U.S. cities. METHODS: We conducted longitudinal analyses (repeated measures mixed models) to assess whether differences in viral load levels, undetectable viral load and self-reported HIV medication adherence were associated with count of syndemic conditions (substance use, depression symptoms and sexual risk behaviour, range 0-3), adjusting for race/ethnicity, age and income. Mediation analyses were conducted using structural equation modelling and the SAS %mediate macro. RESULTS: Syndemics count was associated with higher viral loads (P < 0.0001) and lower adherence (P < 0.0001). Increased counts of concomitant syndemics were associated with viral load (P < 0.01), detectable viral load (P < 0.05) and adherence (P < 0.001). Black MSM experienced worse outcomes across domains than white MSM (P < 0.0001) and experienced higher overall rates of syndemics (P < 0.01). Adherence significantly mediated the relationship between syndemics and viral load, accounting for an estimated 32.3% of the effect (P < 0.05). CONCLUSION: Effectively lowering viral load levels among MSM has implications for both HIV/AIDS prevention and care. Our findings suggest that integrating substance use interventions, mental healthcare and sexual risk prevention into standard HIV care may be necessary to optimize treatment and Treatment as Prevention (TasP) models.
Authors: Anthony J Silvestre; John B Hylton; Lisette M Johnson; Carmoncelia Houston; Mallory Witt; Lisa Jacobson; David Ostrow Journal: Am J Public Health Date: 2006-05-02 Impact factor: 9.308
Authors: Gregorio A Millett; John L Peterson; Stephen A Flores; Trevor A Hart; William L Jeffries; Patrick A Wilson; Sean B Rourke; Charles M Heilig; Jonathan Elford; Kevin A Fenton; Robert S Remis Journal: Lancet Date: 2012-07-20 Impact factor: 79.321
Authors: Charles H Hinkin; Terry R Barclay; Steven A Castellon; Andrew J Levine; Ramani S Durvasula; Sarah D Marion; Hector F Myers; Douglas Longshore Journal: AIDS Behav Date: 2007-03
Authors: C A Kleeberger; J P Phair; S A Strathdee; R Detels; L Kingsley; L P Jacobson Journal: J Acquir Immune Defic Syndr Date: 2001-01-01 Impact factor: 3.731
Authors: Moupali Das; Priscilla Lee Chu; Glenn-Milo Santos; Susan Scheer; Eric Vittinghoff; Willi McFarland; Grant N Colfax Journal: PLoS One Date: 2010-06-10 Impact factor: 3.240
Authors: Judith A Cook; Jane K Burke-Miller; Mardge H Cohen; Robert L Cook; David Vlahov; Tracey E Wilson; Elizabeth T Golub; Rebecca M Schwartz; Andrea A Howard; Claudia Ponath; Michael W Plankey; Alexandra M Levine; Andrea Levine; Dennis D Grey Journal: AIDS Date: 2008-07-11 Impact factor: 4.177
Authors: Kathryn E Muessig; Sara LeGrand; Keith J Horvath; José A Bauermeister; Lisa B Hightow-Weidman Journal: Curr Opin HIV AIDS Date: 2017-09 Impact factor: 4.283
Authors: Kate Buchacz; Carl Armon; Ellen Tedaldi; Frank J Palella; Richard M Novak; Douglas Ward; Rachel Hart; Marcus D Durham; John T Brooks Journal: AIDS Res Hum Retroviruses Date: 2018-02-13 Impact factor: 2.205
Authors: Erin E Sundermann; Robert K Heaton; Elizabeth Pasipanodya; Raeanne C Moore; Emily W Paolillo; Leah H Rubin; Ronald Ellis; David J Moore Journal: AIDS Date: 2018-11-28 Impact factor: 4.177
Authors: Cristian J Chandler; Leigh A Bukowski; Derrick D Matthews; Mary E Hawk; Nina Markovic; James E Egan; Ronald D Stall Journal: AIDS Behav Date: 2020-02
Authors: M Reuel Friedman; Robert W S Coulter; Anthony J Silvestre; Ron Stall; Linda Teplin; Steve Shoptaw; Pamela J Surkan; Michael W Plankey Journal: AIDS Care Date: 2016-07-25